ABT vs MDT — Key Metrics
| Metric | ABT (ABBOTT LABORATORIES) | MDT (MEDTRONIC PLC) |
|---|---|---|
| Price | 98.83 | 86.29 |
| Market Cap | 171.01 Billion | 110.38 Billion |
| P/E (TTM) | 31.88 | 21.1 |
| P/B (Quarterly) | 3.586 | 2.371 |
| P/S (TTM) | 3.67 | 2.94 |
| Net Profit Margin (TTM) | 11.6 | 13.9 |
| Gross Margin (TTM) | 56.6 | 65.0 |
| ROE (TTM) | 10.4 | 10.6 |
| Revenue Growth YoY (TTM) | None | None |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
ABT · ABBOTT LABORATORIES
Outperform
MDT · MEDTRONIC PLC
Outperform
Recommendation Summary
Both stocks are projected to outperform the market over the next year. If you have to make a choice, Upfront Recommendation: MDT.
Financial Metrics
Prices delayed ~15 min
| ABT | Metrics | MDT |
|---|---|---|
| $98.83 | Price | $86.29 |
| — | Market Capitalization | — |
| 31.88 | Price to Earnings Ratio | 21.1 |
| 3.67 | Price to Sales | 2.94 |
| 21.86 | Price to FCF Ratio | 18.0 |
| 6.48 | Price to Gross Profit | 4.52 |
| 54.12 | Price to R&D | 37.83 |
| 6.98 | Price to Current Assets | 4.53 |